Sample collection and DNA preservation device
20170350797 · 2017-12-07
Inventors
Cpc classification
B01L2300/021
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/16
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0609
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N1/28
PHYSICS
Abstract
The present invention relates to a biological sample collection kit, which uses a unique dry preservative for the preservation of nucleic acids, DNA and RNA, for collection, stabilization, transportation and long-term room temperature storage of biological samples that can be from sources such as saliva for molecular diagnostic applications. The invention features a collection device for biological samples such as saliva containing nucleic acids, and dry preservatives that are affixed directly or to a carrier substrate and placed within the collection device such that the samples come into contact with the dry preservatives resulting in the preservation and stabilization of the nucleic acids.
Claims
1. A saliva collection device for preserving nucleic acids, comprising: a container having an interior surface; a first dry preservative affixed onto a first portion of the interior surface of said container; a second dry preservative affixed onto a second portion of the interior surface of said container; and a cap.
2. The device of claim 1, wherein the first dry preservative is a compound comprising a denaturing agent.
3. The device of claim 2, wherein the compound further comprises a chelating agent.
4. The device of claim 3, wherein the compound further comprises a pH buffer.
5. The device of claim 1, wherein the first dry preservative is a compound comprising sodium dodecyl sulfate.
6. The device of claim 5, wherein the compound further comprises CDTA, 1, 2-CyclohexaneDiamineTetraAcetic Acid.
7. The device of claim 6, wherein the compound further comprises urea.
8. The device of claim 7, wherein the compound further comprises NaOAc/Tris.
9. The device of claim 8, wherein the compound further comprises Polyethylene Glycol 8000.
10. The device of claim 9, wherein the compound further comprises 1,2-Propanediol.
11. The device of claim 1, wherein the second dry preservative comprises a protease.
12. The device of claim 1, wherein the second dry preservative comprises Proteinase K.
13. The device of claim 1, wherein the container is a tube.
14. The device of claim 1, wherein the container is a vial.
15. The device of claim 1, wherein the first dry preservative is included in a substrate, said substrate being affixed to said first portion of the interior surface of said container.
16. The device of claim 15, wherein the substrate is paper.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0011]
DETAILED DESCRIPTION OF THE INVENTION
[0012] The present invention is directed to biological collection and preservation kits including a collection device that can collect and preserve nucleic acids DNA and RNA from biological samples such as saliva.
[0013] An embodiment of a saliva collection kit according to the invention may comprise the following: a collection interface 40 that may be a saliva funnel; a tube, vial or vessel 30 for the collection of the saliva sample; dry preservatives 10, 20 stored within the tube, vial or vessel 30 that will preserve and stabilize the nucleic acids DNA and RNA in the saliva on contact; a sealing mechanism 50 for the tube, vial or vessel such as a cap; unique serialization information in barcode and/or RF ID form to identify the kit and the source of the saliva; an optional mechanism for recording user information on the tube, vial or vessel; an optional mechanism to assist in the application of pre-analysis chemistry; an end-user delivery container to hold and deliver the aforementioned components for use along with instructions; and a return container to provide for storage and shipping of collected samples to a lab for processing.
[0014] The components of the kit are interconnected as follows. The end-user delivery container for the kit contains the instructions, the collection tube, vial or vessel 30 with a pre-attached saliva collection interface 40 (such as a funnel) and the sealing mechanism 50 or cap. The unique identifying barcode or RF ID is permanently embedded in or attached to the tube, vial or vessel 30 during manufacturing or prior to delivery to the end-user. The end-user delivery container may be reused as a return container, or a return container may be provided with it. The return container may incorporate a biohazard bag or other leak-proof means of enclosing the tube, vial or vessel containing biological samples. A return shipping label and/or prepaid postage may also be included with the end-user delivery container for use with the return container. Information identifying the end user or the sample can be directly recorded onto the tube, vial, or vessel at the time of collection. One or more dry preservative substances or compounds 10, 20 are applied to the inside of the tube, vial or vessel 30 such that they become affixed and won't spill out. The preservatives 10, 20 may be applied directly to the interior surface of the tube or cap, or they may be applied on to a substrate that is then affixed within the tube 30, or a combination of these approaches may be used. The dry preservative may be applied to the surface of the substrate, tube, vial or vessel as a liquid which then is dried into place. The preservatives 10, 20 are preferably located inside the tube 30 such that they come into contact as soon as possible with the collected saliva.
[0015] In one embodiment of the invention the dry preservative comprises a blend of reagents and enzymes that allow for complete lysis and stabilization of the nucleic acids DNA and RNA and easy transportation and long-term storage of samples at room temperature prior to genetic analysis. The key ingredients of the preservatives have the following functions: Ingredient A—denatures enzymes, including nucleases, including DNase enzymes; Ingredient B—chelates metal cofactors required by DNase enzymes; Ingredient C—denatures enzymes and helps reduce viscosity of saliva along with other supporting chemicals; Ingredient D—hydration agent; Ingredient E—a pH buffer to ensure a desired pH is achieved in the resulting preservative and to contribute to DNA and RNA precipitation; Ingredient F—encourages DNA and RNA precipitation; Ingredient G—modifies the sample's viscosity and surface tension; Ingredient H—digests nucleases in the sample. In one embodiment, the ingredients are combined to form two separate dry preservatives. The first preservative 10 comprises ingredients A through F and may also comprise ingredient G. The second preservative 20 comprises ingredient H and may also comprise ingredient F and/or G.
[0016] Ingredient A may be a substance such as Sodium Dodecyl Sulfate or similar. Ingredient B may be a substance such as CDTA, 1,2-CyclohexaneDiamineTetraAcetic Acid or similar. Ingredient C may be a substance such as urea or similar. Ingredient D may be a substance such as 1,2-Propanediol or similar. Ingredient E may be a substance such as NaOAc/Tris or similar. Ingredient F may be a substance such as Polyethylene Glycol 8000 or similar. Ingredient G may be a surfactant such as Hexadecyltrimethylammonium Chloride or similar. Ingredient H may be a substance such as Proteinase K or similar.
[0017]
[0018] In one embodiment the vial 30 is made of polypropylene, has a capacity of 5 mL, and the fill line 60 is at 3 mL. The carrier substrate coated with the first preservative may be a piece of chromatography paper, 43×20 mm, and may be held in position by a silicone retention ring. The second preservative may comprise a dried solution of Proteinase K, and may also comprise Polyethylene Glycol 8000 and a surfactant. The first preservative may comprise a dried solution of the following ingredients: Sodium Dodecyl Sulfate; 1, 2-CyclohexaneDiamineTetraAcetic Acid; Urea; NaOAc/Tris (stock: 2M NaOAc, 0.5M Tris, PH8.0); Polyethylene Glycol 8000; 1,2-Propanediol, Sodium Hydroxide (to adjust pH) and may also comprise a surfactant such as, for example, Hexadecyltrimethylammonium Chloride.
[0019] A method according to the invention may comprise the following steps: 1. Unbox kit from initial shipping container; 2. Remove kit package (plastic thermoform or similar); 3. Open kit package and remove sample collection tube 30, which includes a pre-attached funnel 40; 4. Open the funnel 40 if necessary (the funnel may feature a flip top cap 70) and spit or drool into the funnel to collect the saliva and fill the tube 30 until the collected saliva, not counting bubbles or foam, reaches the fill line 60; 5. Remove the funnel 40, if removable, and discard it; 6. Seal the tube 30 using the included cap 50; 7. Invert the vessel to accelerate mixing of the saliva with the dry preservatives 10 and 20; 8. Record user or sample identifying information onto the tube if desired; 9. Place the sealed tube 30 into the biohazard bag or other leak-proof storage or shipping enclosure; 10. The sample is ready for processing or it can be placed into the shipping package, should one have been provided, for storage and/or laboratory processing; 11. Upon processing the pre-analysis feature can be utilized if the collection device is so equipped; 12. Sample process and analysis is conducted via the recommended nucleic acid (DNA and RNA) isolation process and then carried out via the laboratory's protocol.
[0020] All references, issued patents and patent applications cited within the body of the instant specification are hereby incorporated by reference in their entirety, for all purposes. While the invention has been described above in terms of specific embodiments, it is to be understood that the invention is not limited to these disclosed embodiments. Many modifications and other embodiments of the invention will come to mind of those skilled in the art to which this invention pertains, and which are intended to be and are covered by both this disclosure and the appended claims.